Shares of this oncology-focused medical device company continue their electrifying run.
News & Analysis: Novocure
NVCR earnings call for the period ending June 30, 2019.
Shares jump after the company reports strong quarterly results and management shares some news about Medicare.
The innovative oncology company posted 41% revenue growth and achieved positive operating income for the first time in its history.
Shares of this medical device company continue their electrifying 2019 run.
These three businesses are a great way for investors to support the war on cancer.
The cancer-focused medical-device maker received the go-ahead to enter a brand-new market. Here's why the news should make investors giddy.
Shares of this medical device company that's aiming to revolutionize cancer treatment bucked last month's downtrend.
Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
Management talks about international expansion, potential FDA approval, and Medicare reimbursement.